tag:blogger.com,1999:blog-10000891.post7518374054571661448..comments2024-02-21T19:56:57.057-08:00Comments on California Stem Cell Report: California Stem Cell Agency Expected to Pump $14 Million into Revival of hESC Clinical Trial Dropped by GeronDavid Jensenhttp://www.blogger.com/profile/00077329461962729362noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-10000891.post-42799498527339889852014-05-23T15:36:02.128-07:002014-05-23T15:36:02.128-07:00Thanks for the heads up, anonymous. We had become ...Thanks for the heads up, anonymous. We had become aware of the change earlier today but were traveling and did not have to time make the fix. We hope to have a few more details later on Okarma's departure. David Jensenhttps://www.blogger.com/profile/00077329461962729362noreply@blogger.comtag:blogger.com,1999:blog-10000891.post-37838836804948400302014-05-23T13:09:28.926-07:002014-05-23T13:09:28.926-07:00A correction to this story: Tom Okarma no longer h...A correction to this story: Tom Okarma no longer heads Asterias. Apparently a coup took place last month that ousted Okarma and replaced him with Michael West as CEO, and 2 BioTime and Asterias board members resigned in protest (reported in April 11 and 14 SEC 8-K filings). BioTime's falling stock price and financial predicament may have been factors. Anonymousnoreply@blogger.com